Drug intelligence / Profile preview

OvaZoa M

Development stage: Unknown
Lead developer: MMC Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

OvaZoa M is a multi-ingredient nutritional supplement developed by MMC Healthcare (also known as MMC Pharmaceuticals) for the support of male reproductive health and fertility. Specifically available in a 20-gram sachet formulation, it contains a combination of Acetyl-L-carnitine, L-carnitine, Astaxanthin, myo-inositol, taurine, L-arginine, zinc, and L-methylfolate calcium. The supplement is designed to improve sperm parameters such as count, motility, and morphology by providing antioxidant protection against oxidative stress and supporting mitochondrial energy metabolism within sperm cells. It is currently approved and marketed in India as a nutraceutical intervention for male infertility.

Brand names: OvaZoa M
Other names: OvaZoa M Softgels

Beyond the preview

Go deeper on OvaZoa M.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OvaZoa M.

Explore the full profile